Atlas Trials

Prospective, Multicenter Study on the Association Between Serum Ustekinumab Levels and Clinical, Biological and Endoscopic Remission in Patients With Crohn's Disease.

Clinical trial NCT07100093 · COMPLETED

Trial details

NCT number
NCT07100093
Sponsor
Hospital Universitario La Paz
Status
COMPLETED
Study type
OBSERVATIONAL
Ustekinumab Serum Levels in Patients With Crohn´s Disease
Start date
2021-07-01
Primary completion
2021-12-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.